4//SEC Filing
BIOMARIN PHARMACEUTICAL INC 4
Accession 0001140361-14-044477
$BMRNCIK 0001048477operating
Filed
Dec 7, 7:00 PM ET
Accepted
Dec 8, 6:50 PM ET
Size
8.8 KB
Accession
0001140361-14-044477
Insider Transaction Report
Form 4
LEWIS ALAN
Director
Transactions
- Sale
Common Stock
2014-12-04$89.90/sh−7,500$674,225→ 21,400 total - Exercise/Conversion
Common Stock
2014-12-04$21.51/sh+7,500$161,325→ 28,900 total - Exercise/Conversion
Stock Option (right to buy)
2014-12-04−7,500→ 0 totalExercise: $21.51From: 2010-11-12Exp: 2020-11-11→ Common Stock (7,500 underlying)
Footnotes (3)
- [F1]The price in column 4 is a weighted average price. The price actually received ranged from $89.8940 to $89.94. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F2]Option grant vest 6/48th on November 12, 2010, and 1/48 on the 12th day of every month thereafter
- [F3]Reflects the number of stock options outstanding after the transaction from this specific stock option grant.
Documents
Issuer
BIOMARIN PHARMACEUTICAL INC
CIK 0001048477
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001048477
Filing Metadata
- Form type
- 4
- Filed
- Dec 7, 7:00 PM ET
- Accepted
- Dec 8, 6:50 PM ET
- Size
- 8.8 KB